Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NTLA

Intellia Therapeutics, Inc.

CIK 0001652130 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$15.44
↓ 1.40 (-8.31%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$2.16B
P/E Ratio
-5.47
EPS
-3.81
Dividend Yield
Not covered
52W Position
37%
Beta
2.32

Valuation multiples

Fwd P/E
Not covered
PEG
-0.10
P/B
3.47
P/S
32.64
EV/Revenue
30.60
ROE
-63.5%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 37%
$7.95$28.25

Latest Financials

2025-12-31 FY
Revenue
$67.67M
Net Income
-$412.69M
Total Assets
$842.13M
Free Cash Flow
-$395.87M

Recent news